Skip to main
MCK

McKesson (MCK) Stock Forecast & Price Target

McKesson (MCK) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

McKesson is well-positioned for growth in the US and Canadian pharmaceutical wholesale markets, as well as through medical-surgical supplies and technology solutions for pharmacies. With a strong focus on high-growth segments, diversification of services, and strategic partnerships, the company has the potential to continue generating strong financial results despite potential challenges in the healthcare industry. They also have a strong balance sheet and have actively repurchased shares to return value to shareholders.

Bears say

McKesson is facing several challenges in the near future, including regulatory changes in drug pricing and the growth of biosimilars. However, its strong infrastructure and focus on specialty pharma, as well as its plans to focus on higher-growth areas, may help mitigate these risks and contribute to potential growth for the company in the long term. The upside scenario presented in the article also suggests potential for increased profits and earnings for McKesson in the coming years.

McKesson (MCK) has been analyzed by 15 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of McKesson and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About McKesson (MCK) Forecast

Analysts have given McKesson (MCK) a Buy based on their latest research and market trends.

According to 15 analysts, McKesson (MCK) has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $947.53, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $947.53, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

McKesson (MCK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.